Clinical Trials Browser

Carcinoma, Merkel Cell × cemiplimab × 90 days × Clear all

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT07387198 2026-02-04

NeoMatryx

Phase 2 Not yet recruiting

Skin Neoplasms, Carcinoma, Merkel Cell